02.05.2014 • News

Nova Chemicals CEO Woelfel Resigns Post

Randy Woelfel resigned as CEO of Canada's Nova Chemicals on May 1. His departure was announced shortly before the company's first-quarter earnings conference call.

In a statement the Canadian chemical producer said its board of directors and chief executive had been unable to agree on mutually satisfactory contract renewal terms and that the resignation was not due to differences of opinion about Nova's overall business strategy.

Todd Karran, the company's chief financial officer, has been appointed acting CEO to serve until a permanent chief executive has been found. Woelfel had headed Nova since 2009.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.